Experts Advise Against Universal DNA Sequencing of Newborns

Share this content:
Experts Advise Against Universal DNA Sequencing of Newborns
Experts Advise Against Universal DNA Sequencing of Newborns

THURSDAY, Sept. 13, 2018 (HealthDay News) -- Newborns should not undergo universal sequencing at birth, according to a report published in the July/August issue of The Hasting Center Report.

Josephine Johnston, J.D., from The Hastings Center in Garrison, N.Y., and colleagues address ethical and other considerations surrounding sequencing of newborns at birth, which experts claim may facilitate a lifetime of personalized medical care.

The authors note that targeted or whole-exome or whole-genome sequencing can be used to assist in the diagnosis of symptomatic newborns, with parental permission and access to genetic counseling and follow-up. Given the limited usefulness of sequencing in asymptomatic populations, concerns regarding storage of results, potential discriminatory or insurance uses, and the potential for results causing unnecessary distress, genome‐wide sequencing should not be used as a screening tool. Whole-exome or whole-genome sequencing should not be used as a sole screen for newborns; targeted sequencing can be used as a secondary test, or as a primary test, where sequencing is the more appropriate or only method for screening. Direct-to-consumer sequencing should not be used for diagnosis or screening of newborns.

"Genomics is a powerful tool, but the results it returns are still not fully understood and have not been proven to advance health outside of very specific clinical situations," Johnston said in a statement. "The recommendations embrace the use of genomics to aid in the diagnosis of sick newborns, but they draw a sharp distinction between that kind of focused clinical use and population screening."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC Identifies Drugs Frequently Involved in Drug Overdose Deaths

CDC Identifies Drugs Frequently Involved in Drug Overdose ...

Oxycodone, heroin, and fentanyl ranked first in 2011, 2012-2015, 2016; cocaine ranked second or third

2017 Saw Slowing in National Health Care Spending

2017 Saw Slowing in National Health Care Spending

Slower growth in health care spending mainly due to use and intensity of goods and services

Inflammatory Bowel Disease, Prostate Cancer Linked

Inflammatory Bowel Disease, Prostate Cancer Linked

At age 60, men with inflammatory bowel disease have higher values of prostate-specific antigen

is free, fast, and customized just for you!




Already a member?

Sign In Now »